This strategy could be effective as it can target also the pro-osteoclastogenic effect of C5a that in the inflammed bone, as happens in RA and bone healing, enhances the inflammatory response of osteoblasts and increases osteoclast formation (Hornum et al., 2017; Modinger et al., 2018). This evidence concerns the gene C5 and rheumatoid arthritis.